![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitor... Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include CYC065 CDK inhibitor, Sapacitabine and seliciclib, CYC682, CYC140 PLK inhibitor, and CYC202. It earns the majority of its revenue from the United Kingdom. Show more
/jornal/2024/08/petrobras-conclui-testes-do-projeto-piloto-do-modelo-gemeo-digital-nas-plataformas-e-pode-elevar-producao-em-1/
/jornal/2024/08/petrobras-inicia-estudos-para-a-implantacao-de-nova-plataforma-em-buzios/
/jornal/2024/08/petrobras-diz-que-avalia-decisao-do-tcu-sobre-unigel/
/jornal/2024/08/petrobras-lanca-ferramenta-digital-para-incentivar-o-abatimento-de-co2-no-pais/
/jornal/2024/08/petrobras-anuncia-pagamento-de-dividendos-e-juros-sobre-capital-proprio-no-valor-de-r-13-57-bilhoes/
/jornal/2024/08/petrobras-petr4-prejuizo-liquido-de-r-2-605-bilhoes-2t24/
/jornal/2024/08/petrobras-lanca-inteligencia-artificial-capaz-de-identificar-bens-ocultos-em-investigacoes-de-enriquecimento-ilicito/
/jornal/2024/08/petrobras-due-diligence-da-refinaria-de-mataripe-esta-em-fase-de-conclusao/
/jornal/2024/08/petrobras-aguarda-regras-do-leilao-de-capacidade-de-energia-para-definir-colocacao-de-termicas/
/jornal/2024/08/supergerente-da-petrobras-busca-aproximar-gerencias-e-otimizar-projetos-evitando-sobras-bilionarias-de-capex/
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | PR |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | PR |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | PR |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | PR |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | PR |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | PR |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | PR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions